Singapore markets close in 7 hours 48 minutes

Mainz Biomed N.V. (4TO.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
0.6820-0.0270 (-3.81%)
At close: 07:26PM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 15.03M
Enterprise value 15.35M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)13.78
Price/book (mrq)5.12
Enterprise value/revenue 17.15
Enterprise value/EBITDA -0.62

Trading information

Stock price history

Beta (5Y monthly) 0.24
52-week change 3-84.74%
S&P500 52-week change 322.38%
52-week high 35.4700
52-week low 30.6700
50-day moving average 30.8843
200-day moving average 31.6614

Share statistics

Avg vol (3-month) 32.2k
Avg vol (10-day) 31.84k
Shares outstanding 521.89M
Implied shares outstanding 622.03M
Float 818.39M
% held by insiders 121.63%
% held by institutions 11.06%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-3,068.71%

Management effectiveness

Return on assets (ttm)-93.42%
Return on equity (ttm)-303.20%

Income statement

Revenue (ttm)895.48k
Revenue per share (ttm)0.05
Quarterly revenue growth (yoy)11.10%
Gross profit (ttm)N/A
EBITDA -26.07M
Net income avi to common (ttm)-26.3M
Diluted EPS (ttm)-1.4500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)7.07M
Total cash per share (mrq)0.32
Total debt (mrq)7.42M
Total debt/equity (mrq)228.39%
Current ratio (mrq)0.97
Book value per share (mrq)0.15

Cash flow statement

Operating cash flow (ttm)-21.94M
Levered free cash flow (ttm)-13.61M